Published Online: Monday, January 1, 2007

As of May 2007, the Department of Defense (DOD) will begin substitution of certain OTC drugs that have been assessed as both cost-effective and therapeutically equivalent to prescription drugs on the TRICARE formulary.

The program can be put into operation across the entire DOD pharmacy benefits program or at a limited number of locations, according to the discretion of the new secretary of defense. If the extent of the project is limited, however, it must be implemented in at least 5 outlets in each of the 3 TRICARE regions across the country. The legislation calls for a report evaluating the saved costs and benefits seen in providing OTC drugs under the pharmacy benefits program, including a gauge of customer satisfaction, to be included within the next 2 years.

TRICARE is the DOD's managed health care program for active-duty military personnel, active-duty service families, and military retirees and their families. The program covers 9 million individuals worldwide.

Latest Articles
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Latest Issues